SSBI 14.20 Summit State Bank $SSBI Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board

Nov 4, 2014 at 1:42 AM

SSBI 14.20 Summit State Bank $SSBI Hit a 52 week high of 14.26 Closing the day 11/03/14 at 14.20 +1.32 +10.25% With a day low of 12.96 and a total volume of 20,995.

SSBI Recent Posts: http://investorshangout.com/Summit-State-Bank-SSBI-55526/

SSBI Summit State Bank Recent Headline News

Summit State Bank Reports 6% Increase in Profitability and Declaration of Dividend
GlobeNewswire - Tue Oct 28, 10:00AM CDT
Summit State Bank (Nasdaq:SSBI) today reported net income for the quarter ended September 30, 2014 of $1,183,000, a 6% increase over the quarter ended September 30, 2013. A quarterly dividend of $0.11 per share was declared for common shareholders.
SSBI: 14.20 (+1.32)

Summit State Bank Recognized Again as a Top Corporate Philanthropist in the Bay Area
GlobeNewswire - Mon Jul 14, 1:07PM CDT
Summit State Bank (Nasdaq:SSBI) received recognition for the second consecutive year as one of the Top 75 Corporate Philanthropists in the Bay Area by the San Francisco Business Times. Summit State Bank remained the only Sonoma County-based company to earn this recognition.
SSBI: 14.20 (+1.32)

Cost Containment Continues at Westamerica - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 4:10PM CDT
On March 25, 2014, we have issued an updated research report on Westamerica Bancorp.
WABC: 49.17 (-0.17), COLB: 27.68 (-0.10), SSBI: 14.20 (+1.32), CVCY: 10.80 (-0.01)

SVB Financial Upped to Strong Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 31, 4:00PM CDT
SVB Financial has been witnessing rising earnings estimates on the back of strong fourth-quarter 2013 results, which included improved revenues, growth in deposits & loans and a steady capital position.
AMRB: 9.70 (+0.32), SSBI: 14.20 (+1.32), SIVB: 111.73 (-0.26), CVCY: 10.80 (-0.01)

Preferred Bank Crafts 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 9:35AM CDT
Shares of Preferred Bank hit a new 52-week high of $26.79 during the first half of the trading session on March 26.
PFBC: 26.30 (-0.28), BOH: 58.48 (-0.07), SSBI: 14.20 (+1.32), CVCY: 10.80 (-0.01)

Bank of Hawaii Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 25, 3:45PM CDT
Shares of Bank of Hawaii Corporation crafted a new 52-week high, touching $61.36 on Mar 24.
PFBC: 26.30 (-0.28), BOH: 58.48 (-0.07), SSBI: 14.20 (+1.32), CVCY: 10.80 (-0.01)

Mixed Thoughts on Zions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 4:05PM CDT
Recently we issued an updated research report on Zions Bancorp. (ZION) based on mixed sentiments.
PFBC: 26.30 (-0.28), SSBI: 14.20 (+1.32), BSRR: 17.00 (-0.16), ZION: 29.06 (+0.09)

Peregrine Announces Ch-6 Independent Diamond Valuation Results
Marketwire - Wed Feb 26, 7:11AM CST
Peregrine Diamonds Ltd. ("Peregrine" or "the Company"

(TSX: PGD) is pleased to announce the results of an independent diamond valuation for a 1,013.5 carat parcel of commercial-size diamonds recovered from the CH-6 kimberlite pipe. The average price was US$213 per carat and the entire parcel was valued at US$215,605. The modelled price ranged from a minimum of US$162 per carat to a high of US$236 per carat with a base case modelled price of US$188 per carat. The grade of the 404.2 tonne bulk sample that yielded the 1,013.5 carat parcel was 2.58 carats per tonne ("CPT"

for diamonds larger than the 1.18 mm square mesh sieve size. Within the parcel, the four largest diamonds weighing 8.87, 5.83, 4.62 and 4.11 carats had per carat market values of US$4,076, US$3,455, US$2,900 and US$2,633 respectively. The CH-6 kimberlite is located on Peregrine's 100 percent-owned Chidliak diamond project ("Chidliak" or "the Project"

, on Baffin Island, 120 kilometers from Iqaluit, the capital of Nunavut, Canada.
SSBI: 14.20 (+1.32), PGD.TO: 0.19 (+0.01)

Balanced Risk-Reward for PNC Financial - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 4:40PM CST
On Feb 18, 2014, we issued an updated research report on The PNC Financial Services Group. Inc.
OLBK: 15.92 (-0.06), SSBI: 14.20 (+1.32), SYBT: 33.22 (-0.06), PNC: 86.54 (+0.15)

BofI Holding Touches 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 12:20PM CST
Shares of BofI Holding achieved a new 52-week high, reaching $87.36 in the second half of the trading session on Feb 18. Notably, the stock closed the session at $86.80, which reflects a solid year-to-date return of 14.3%.
PFBC: 26.30 (-0.28), BOFI: 76.11 (-0.91), WAL: 26.42 (-0.20), SSBI: 14.20 (+1.32)

Summit State Bank Announces Election of Directors
GlobeNewswire - Tue Jul 30, 6:00PM CDT
Summit State Bank (Nasdaq:SSBI) today announced the election of directors. The following were elected directors: Jeffrey B. Allen, James E. Baxter II, James E. Brush, Josh C. Cox, Jr., John F. DeMeo, Michael J. Donovan, Richard A. Dorr, Thomas M. Duryea, Todd R. Fry, Allan J. Hemphill, Samuel G. Kapourales, Ronald A. Metcalfe, Richard E. Pope, Nicholas J. Rado, Marshall T. Reynolds, and Eugene W. Traverso. Allan Hemphill has been elected as the Chairman of the Board.
SSBI: 14.20 (+1.32)

Summit State Bank Reports 64% Increase in Profitability and Dividend Increase
GlobeNewswire - Mon Apr 29, 7:14PM CDT
Summit State Bank (Nasdaq:SSBI) today reported net income for the quarter ended March 31, 2013 of $1,002,000, a 64% increase over the quarter ended March 31, 2012. A quarterly dividend of $0.11 per share was declared for common shareholders.
SSBI: 14.20 (+1.32)

Summit State Bank Reports a 55% Increase in Earnings for 2012 and Declaration of Dividend
GlobeNewswire - Mon Jan 28, 5:30PM CST
Summit State Bank (Nasdaq:SSBI) today reported net income for the year ended December 31, 2012 of $3,448,000, a 55% increase over 2011. Earnings per share increased to $0.62 in 2012 from $0.33 in 2011.
SSBI: 14.20 (+1.32)

Summit State Bank (SSBI) Stock Research Links

SSBI Board Company Profile Buy Rating Time & Sales News Filings Financials

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

El Pollo Loco Faces Class Action Over Wage Practices

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

HiTHIUM Joins Cambridge to Boost Global Energy Storage

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Fluence Energy Faces Leadership Departures Amid Legal Woes

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...